Experimental and clinical studies on the intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers

Toshiharu Furukawa, Koichiro Kumai, Tetsuro Kubota, Shinobu Hirahata, Hiroyuki Shimizu, Hideo Matsui, Tetsuya Takahara, Ken Ichiro Aizawa, Sansei Shibata, Atsushi Shimada, Keiichi Yoshino, Kyuya Ishibiki, Masaki Kitajima

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The effectiveness of the intraperitoneal administration of cis-diamminedichloroplatinum (II) (DDP) on peritoneal carcinomatosis caused by gastric cancers was evaluated. Seventeen patients were treated with one of three protocols, consisting of the intraperitoneal injection (ip) of DDP at doses of 70 and 110 mg/m2, with or without sodium thiosulfate (STS) rescue. The area under the curve (AUC) of DDP for sufficient anticancer activities against cultured human cell lines in vitro was estimated at 240 μg h/ml, which was equivalent to the AUC gained by 110 mg/m2 ip DDP in the clinical studies. The cytotoxic activity of DDP was reduced by approximately 50% with 100-fold STS in the AUC in the experimental studies. However, this was achieved only in urine, and not in either the peritoneal cavity or in plasma in the clinical studies. Three cases of a partial response against peritoneal carcinomatosis were seen from a total of four evaluable cases treated with 110 mg/m2 DDP, and no renal toxicities were observed in those treated with the STS rescue. The results of this study led us to conclude that high-dose ip DDP treatment combined with the STS rescue would be useful chemotherapy against peritoneal carcinomatosis caused by gastric cancers.

Original languageEnglish
Pages (from-to)298-306
Number of pages9
JournalSurgery Today
Volume23
Issue number4
DOIs
Publication statusPublished - 1993 Apr

Fingerprint

Cisplatin
Stomach Neoplasms
Area Under Curve
Carcinoma
Peritoneal Cavity
Intraperitoneal Injections
Cultured Cells
Urine
Kidney
Drug Therapy
Cell Line
sodium thiosulfate
Clinical Studies
Therapeutics

Keywords

  • cisplatin
  • gastric cancer
  • intraperitoneal chemotherapy
  • peritoneal carcinomatosis
  • sodium thiosulfate

ASJC Scopus subject areas

  • Surgery

Cite this

Experimental and clinical studies on the intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers. / Furukawa, Toshiharu; Kumai, Koichiro; Kubota, Tetsuro; Hirahata, Shinobu; Shimizu, Hiroyuki; Matsui, Hideo; Takahara, Tetsuya; Aizawa, Ken Ichiro; Shibata, Sansei; Shimada, Atsushi; Yoshino, Keiichi; Ishibiki, Kyuya; Kitajima, Masaki.

In: Surgery Today, Vol. 23, No. 4, 04.1993, p. 298-306.

Research output: Contribution to journalArticle

Furukawa, T, Kumai, K, Kubota, T, Hirahata, S, Shimizu, H, Matsui, H, Takahara, T, Aizawa, KI, Shibata, S, Shimada, A, Yoshino, K, Ishibiki, K & Kitajima, M 1993, 'Experimental and clinical studies on the intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers', Surgery Today, vol. 23, no. 4, pp. 298-306. https://doi.org/10.1007/BF00309046
Furukawa, Toshiharu ; Kumai, Koichiro ; Kubota, Tetsuro ; Hirahata, Shinobu ; Shimizu, Hiroyuki ; Matsui, Hideo ; Takahara, Tetsuya ; Aizawa, Ken Ichiro ; Shibata, Sansei ; Shimada, Atsushi ; Yoshino, Keiichi ; Ishibiki, Kyuya ; Kitajima, Masaki. / Experimental and clinical studies on the intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers. In: Surgery Today. 1993 ; Vol. 23, No. 4. pp. 298-306.
@article{b4e8dd8f9f3e495baae2215c17f45156,
title = "Experimental and clinical studies on the intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers",
abstract = "The effectiveness of the intraperitoneal administration of cis-diamminedichloroplatinum (II) (DDP) on peritoneal carcinomatosis caused by gastric cancers was evaluated. Seventeen patients were treated with one of three protocols, consisting of the intraperitoneal injection (ip) of DDP at doses of 70 and 110 mg/m2, with or without sodium thiosulfate (STS) rescue. The area under the curve (AUC) of DDP for sufficient anticancer activities against cultured human cell lines in vitro was estimated at 240 μg h/ml, which was equivalent to the AUC gained by 110 mg/m2 ip DDP in the clinical studies. The cytotoxic activity of DDP was reduced by approximately 50{\%} with 100-fold STS in the AUC in the experimental studies. However, this was achieved only in urine, and not in either the peritoneal cavity or in plasma in the clinical studies. Three cases of a partial response against peritoneal carcinomatosis were seen from a total of four evaluable cases treated with 110 mg/m2 DDP, and no renal toxicities were observed in those treated with the STS rescue. The results of this study led us to conclude that high-dose ip DDP treatment combined with the STS rescue would be useful chemotherapy against peritoneal carcinomatosis caused by gastric cancers.",
keywords = "cisplatin, gastric cancer, intraperitoneal chemotherapy, peritoneal carcinomatosis, sodium thiosulfate",
author = "Toshiharu Furukawa and Koichiro Kumai and Tetsuro Kubota and Shinobu Hirahata and Hiroyuki Shimizu and Hideo Matsui and Tetsuya Takahara and Aizawa, {Ken Ichiro} and Sansei Shibata and Atsushi Shimada and Keiichi Yoshino and Kyuya Ishibiki and Masaki Kitajima",
year = "1993",
month = "4",
doi = "10.1007/BF00309046",
language = "English",
volume = "23",
pages = "298--306",
journal = "Surgery Today",
issn = "0941-1291",
publisher = "Springer Japan",
number = "4",

}

TY - JOUR

T1 - Experimental and clinical studies on the intraperitoneal administration of cis-diamminedichloroplatinum (II) for peritoneal carcinomatosis caused by gastric cancers

AU - Furukawa, Toshiharu

AU - Kumai, Koichiro

AU - Kubota, Tetsuro

AU - Hirahata, Shinobu

AU - Shimizu, Hiroyuki

AU - Matsui, Hideo

AU - Takahara, Tetsuya

AU - Aizawa, Ken Ichiro

AU - Shibata, Sansei

AU - Shimada, Atsushi

AU - Yoshino, Keiichi

AU - Ishibiki, Kyuya

AU - Kitajima, Masaki

PY - 1993/4

Y1 - 1993/4

N2 - The effectiveness of the intraperitoneal administration of cis-diamminedichloroplatinum (II) (DDP) on peritoneal carcinomatosis caused by gastric cancers was evaluated. Seventeen patients were treated with one of three protocols, consisting of the intraperitoneal injection (ip) of DDP at doses of 70 and 110 mg/m2, with or without sodium thiosulfate (STS) rescue. The area under the curve (AUC) of DDP for sufficient anticancer activities against cultured human cell lines in vitro was estimated at 240 μg h/ml, which was equivalent to the AUC gained by 110 mg/m2 ip DDP in the clinical studies. The cytotoxic activity of DDP was reduced by approximately 50% with 100-fold STS in the AUC in the experimental studies. However, this was achieved only in urine, and not in either the peritoneal cavity or in plasma in the clinical studies. Three cases of a partial response against peritoneal carcinomatosis were seen from a total of four evaluable cases treated with 110 mg/m2 DDP, and no renal toxicities were observed in those treated with the STS rescue. The results of this study led us to conclude that high-dose ip DDP treatment combined with the STS rescue would be useful chemotherapy against peritoneal carcinomatosis caused by gastric cancers.

AB - The effectiveness of the intraperitoneal administration of cis-diamminedichloroplatinum (II) (DDP) on peritoneal carcinomatosis caused by gastric cancers was evaluated. Seventeen patients were treated with one of three protocols, consisting of the intraperitoneal injection (ip) of DDP at doses of 70 and 110 mg/m2, with or without sodium thiosulfate (STS) rescue. The area under the curve (AUC) of DDP for sufficient anticancer activities against cultured human cell lines in vitro was estimated at 240 μg h/ml, which was equivalent to the AUC gained by 110 mg/m2 ip DDP in the clinical studies. The cytotoxic activity of DDP was reduced by approximately 50% with 100-fold STS in the AUC in the experimental studies. However, this was achieved only in urine, and not in either the peritoneal cavity or in plasma in the clinical studies. Three cases of a partial response against peritoneal carcinomatosis were seen from a total of four evaluable cases treated with 110 mg/m2 DDP, and no renal toxicities were observed in those treated with the STS rescue. The results of this study led us to conclude that high-dose ip DDP treatment combined with the STS rescue would be useful chemotherapy against peritoneal carcinomatosis caused by gastric cancers.

KW - cisplatin

KW - gastric cancer

KW - intraperitoneal chemotherapy

KW - peritoneal carcinomatosis

KW - sodium thiosulfate

UR - http://www.scopus.com/inward/record.url?scp=0027406533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027406533&partnerID=8YFLogxK

U2 - 10.1007/BF00309046

DO - 10.1007/BF00309046

M3 - Article

C2 - 8318783

AN - SCOPUS:0027406533

VL - 23

SP - 298

EP - 306

JO - Surgery Today

JF - Surgery Today

SN - 0941-1291

IS - 4

ER -